WallStSmart

Coursera Inc (COUR)vsCovista Inc. (CVSA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 149% more annual revenue ($1.89B vs $757.50M). CVSA leads profitability with a 13.4% profit margin vs -6.7%. CVSA earns a higher WallStSmart Score of 67/100 (B-).

COUR

Hold

37

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 5.0Quality: 7.0
Piotroski: 5/9Altman Z: 1.03

CVSA

Strong Buy

67

out of 100

Grade: B-

Growth: 5.3Profit: 7.5Value: 8.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for COUR.

CVSASignificantly Overvalued (N/A)

Margin of Safety

N/A

Fair Value

$97.23

Current Price

$113.08

$15.85 premium

UndervaluedFair: $97.23Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

COUR2 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0110/10

Conservative balance sheet, low leverage

Price/BookValuation
1.5x8/10

Reasonable price relative to book value

CVSA4 strengths · Avg: 8.0/10
PEG RatioValuation
0.818/10

Growing faster than its price suggests

P/E RatioValuation
16.1x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

Operating MarginProfitability
22.9%8/10

Strong operational efficiency at 22.9%

Areas to Watch

COUR4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$993.87M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-8.3%2/10

ROE of -8.3% — below average capital efficiency

Altman Z-ScoreHealth
1.032/10

Distress zone — elevated risk

CVSA1 concerns · Avg: 4.0/10
EPS GrowthGrowth
4.7%4/10

4.7% earnings growth

Comparative Analysis Report

WallStSmart Research

Bull Case : COUR

The strongest argument for COUR centers on Debt/Equity, Price/Book.

Bull Case : CVSA

The strongest argument for CVSA centers on PEG Ratio, P/E Ratio, Price/Book. Revenue growth of 12.4% demonstrates continued momentum. PEG of 0.81 suggests the stock is reasonably priced for its growth.

Bear Case : COUR

The primary concerns for COUR are EPS Growth, Market Cap, Return on Equity.

Bear Case : CVSA

The primary concerns for CVSA are EPS Growth.

Key Dynamics to Monitor

COUR profiles as a turnaround stock while CVSA is a value play — different risk/reward profiles.

COUR carries more volatility with a beta of 1.36 — expect wider price swings.

CVSA is growing revenue faster at 12.4% — sustainability is the question.

CVSA generates stronger free cash flow (15M), providing more financial flexibility.

Bottom Line

CVSA scores higher overall (67/100 vs 37/100) and 12.4% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Coursera Inc

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Coursera, Inc. operates an online educational content platform that connects students, educators, and institutions. The company is headquartered in Mountain View, California.

Visit Website →

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?